Cafepharma Today

June 7 2023 - Study: Biosimilars ‘fulfilling their promise’ of lowering biologic prices
Study: Biosimilars ‘fulfilling their promise’ of lowering biologic prices
After Merck's flashpoint IRA lawsuit, Biogen CEO and others register their own complaints
Zuckerberg cash helping to propel Chicago's biotech ambitions
GSK’s RSV vaccine wins European approval
*please scroll down for all the latest news*

Current News

submit a press release

Click here to stay updated on CP happenings
FDA rejects Clovis' long-shot bid for approval of Rubraca
Fierce Pharma
Monday, June 5, 2023 - 11:29am
tags:
Clovis Oncology, Rubraca, FDA, bankruptcy
Amgen's Horizon buyout delayed again, pushing closure possibly to December
Fierce Pharma
Monday, June 5, 2023 - 10:21am
tags:
Amgen, Horizon Therapeutics, FTC, M&A
ASCO: Affimed pivots to cancer combo after failing to meet monotherapy study continuation criteria
Fierce Biotech
Monday, June 5, 2023 - 10:20am
tags:
Affimed, ASCO 2023, AFM24
Enzo Biochem says ransomware attack exposed clinical test data of 2.5 million patients
TechCrunch
Monday, June 5, 2023 - 10:18am
tags:
Enzo Bioschem, ransomware, cybersecurity
Novavax Partners With Gates Foundation Offshoot In Efforts To Develop Malaria And TB Shots
Forbes
Monday, June 5, 2023 - 10:15am
tags:
Novavax, vaccines, Gates Foundation, malaria, tuberculosis
J&J sees trial data supporting earlier CAR-T use in multiple myeloma
BioPharma Dive
Monday, June 5, 2023 - 10:12am
tags:
ASCO 2023, JNJ, Legend Biotech, Carvykti, CAR-T, Multiple Myeloma
Akero’s NASH drug combined with Ozempic cut liver fat in small study
Stat
Monday, June 5, 2023 - 10:10am
tags:
Akero Therapeutics, efruxifermin, NASH, Ozempic
Could Pfizer Have an Ozempic Killer on the Way?
Motley Fool
Monday, June 5, 2023 - 10:07am
tags:
Pfizer, danuglipron, Novo Nordisk, Ozempic, weight loss
Why Lilly is trying new strokes to persevere against pain
Fierce Biotech
Monday, June 5, 2023 - 10:02am
tags:
Eli Lilly, chronic pain, CROs
ASCO 2023 – Bicara eyes head and neck niche
EP Vantage
Monday, June 5, 2023 - 9:59am
tags:
ASCO 2023, Bicara Therapeutics, BCA101, head and neck cancer
ReCode, Vertex and 4DMT Seek to Help Untreated Cystic Fibrosis Patients
BioSpace
Monday, June 5, 2023 - 9:57am
tags:
cystic fibrosis, ReCode, Vertex Pharmaceuticals, 4DMT
ASCO: Seagen's top-selling drug under threat as Bristol Myers' Opdivo beats Adcetris in lymphoma
Fierce Pharma
Sunday, June 4, 2023 - 4:31pm
tags:
ASCO 2023 - Seagen, Bristol Myers Squibb, Adcetris, Opdivo, antibody-drug conjugate, Hodgkin's lymphoma
Biden plans to pick Mandy Cohen to lead CDC
Stat
Sunday, June 4, 2023 - 4:28pm
tags:
CDC, Joe Biden, Mandy Cohen
ASCO: Gilead and Arcus's Cancer Immunotherapy Combo Faces Scrutiny Over Lower Survival Rates
BioSpace
Sunday, June 4, 2023 - 4:27pm
tags:
ASCO 2023, Gilead Sciences, Arcus Biosciences, anti-TIGIT, non-small cell lung cancer, domvanalimab
MEI Pharma CEO departs as company rejects unsolicited takeover bid
Medical Marketing and Media
Sunday, June 4, 2023 - 4:25pm
tags:
MEI Pharma, Pharma CEOs, Daniel Gold, M&A
ASCO: AstraZeneca guns for wider ovarian cancer market with Imfinzi-Lynparza combo. Will the FDA buy the plan?
Fierce Pharma
Sunday, June 4, 2023 - 4:24pm
tags:
ASCO 2023, AstraZeneca, Lynparza, Imfinzi, ovarian cancer
ASCO: Merck bills Keytruda, used around surgery, as new standard in 'messy' early lung cancer realm
Fierce Pharma
Sunday, June 4, 2023 - 4:22pm
tags:
ASCO 2023, Merck, Keytruda, non-small cell lung cancer
Grail Expands Blood Test to Symptomatic Patients, Aims to Revolutionize Cancer Diagnosis
BioSpace
Sunday, June 4, 2023 - 4:21pm
tags:
Grail, diagnostics, Medtech, Galleri, cancer
Novo Nordisk maintains its defense in case of high-priced insulin – competitor enters settlement
Medwatch
Sunday, June 4, 2023 - 4:19pm
tags:
Novo Nordisk, insulin, diabetes, drug pricing
Novo Nordisk wins age discrimination case in US district court
Medwatch
Sunday, June 4, 2023 - 4:17pm
tags:
Novo Nordisk, age discrimination, legal, EEOC

Pages

Latest CP Wire Articles

Eastman introduces new excipient to formulate poorly soluble API
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award
PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases
Klick Health launches new healthcare venture studio
Medtech earnings reports: insights from major players' Q4 results
Key compliance issues for medtech firms transitioning to data-enabled solutions
Following FDA COVID vaccine advisory panel vote, Novavax is prepared to provide a revised vaccine

Latest Pharmagather Articles

Drug Pricing Restrictions: Oh Joy
In the Pipeline
Just Stick 'Em Together
In the Pipeline
Pharmacist Salaries and Employment in 2022: The Good Times Roll for Retail Pharmacists
Drug Channels
thINc’s Specialty Networks and Patient Support Services Summit
Drug Channels
The Drug Discount Ecosystem’s “Mission Critical”
Drug Channels
Fakin' It the Modern Way
In the Pipeline
Reduction of Tau
In the Pipeline
Timeless
In the Pipeline
Drug Channels News Roundup, May 2023: 340B Shame, OptumRx vs. Humira Biosimilars, ICER on White Bagging, Hospitals vs. Taxes, and Dr. G
Drug Channels

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information